Green Cross Lab Cell Corporation (144510) — Cash Flow-to-Debt Ratio
Green Cross Lab Cell Corporation (144510) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2026, meaning its operating cash flow of ₩208.25 Million could theoretically repay 0% of its total liabilities (₩145.87 Billion) in one year. See Green Cross Lab Cell Corporation (144510) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Green Cross Lab Cell Corporation Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Green Cross Lab Cell Corporation across 11 annual periods. For the full cash flow conversion analysis, see 144510 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Green Cross Lab Cell Corporation (2015–2025)
Year-by-year debt coverage analysis for Green Cross Lab Cell Corporation. Check 144510 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | ₩9.19 Billion | ₩113.31 Billion | ▼ -13.8% |
| 2024 | 0.09x | ₩11.34 Billion | ₩120.56 Billion | ▲ +217.0% |
| 2023 | 0.03x | ₩3.67 Billion | ₩123.69 Billion | ▼ -93.8% |
| 2022 | 0.48x | ₩66.42 Billion | ₩138.07 Billion | ▲ +170.8% |
| 2021 | 0.18x | ₩23.91 Billion | ₩134.57 Billion | ▼ -43.0% |
| 2020 | 0.31x | ₩9.09 Billion | ₩29.19 Billion | ▲ +3254.2% |
| 2019 | 0.01x | ₩223.04 Million | ₩24.02 Billion | ▼ -81.9% |
| 2018 | 0.05x | ₩490.92 Million | ₩9.55 Billion | ▼ -87.4% |
| 2017 | 0.41x | ₩2.86 Billion | ₩7.03 Billion | ▲ +980.1% |
| 2016 | -0.05x | ₩-296.65 Million | ₩6.42 Billion | ▼ -124.6% |
| 2015 | 0.19x | ₩1.49 Billion | ₩7.90 Billion | — |